News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Pharmaceutical industry
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?

In May, Gilead pledged to donate 2.4 million bottles of its HIV drug Truvada to the U.S. government’s effort to eradicate the disease, partly by preventing new infections. But now Gilead is facing accusations that its largesse may have suspicious underpinnings. The House Oversight Committee’s chairman, Rep. Elijah E. Cummings (D-MD), and three colleagues sent a letter to Gilead demanding details about what led to the company’s generous offer.

Published
01 July 2019
From
FiercePharma
Types of HIV tests
Can Self-Swabs Make HIV Exposure and Risk Reporting More Accurate?

A new study conducted in South Africa finds that when cisgender women are given the tools to assess their HIV exposure risk at home, those tools can yield far more accurate results than a sit-down interview with an HIV clinician. The study also pioneered a new use case for swabbing kits, yielding valuable insights that lead author Maria Lemos, Ph.D., says may one day lead to a new method of self-testing for HIV exposure at home.

Published
01 July 2019
From
The Body Pro
Epidemiology
Young sex workers and gay men in Cameroon – at-risk, but with no services

New study highlights unmet HIV prevention and treatment needs of young key affected populations in Cameroon.

Published
01 July 2019
From
Avert
Finance and funding
Theresa May urges other countries to step forward as she unveils £1.4bn in fight against killer diseases

Prime minister Theresa May has urged international leaders at the G20 summit in Japan to follow the UK's lead and commit to fighting the world’s three biggest infectious disease killers, as she unveiled a £1.4 billion funding pledge. In one of her final acts as prime minister Mrs May announced the UK would give £467 million a year over the next three years to the Global Fund to Fight Fight Aids, Tuberculosis and Malaria.

Published
01 July 2019
From
Telegraph
History of HIV and AIDS
How a Dying Ryan White United Washington on the AIDS Crisis

In the late ’80s, getting Congress or the White House to fund anything having to do with AIDS was a non-starter. Advocates needed a miracle. And they got one.

Published
01 July 2019
From
Daily Beast
Global health initiatives
Yes, we really do need UNAIDS

As the global network of people living with a disease that still infects 1.8 million people every year and kills another 1 million annually, GNP+ can say loud and clear: Yes, we absolutely need UNAIDS as a distinct body that leads and co-ordinates the HIV response.

Published
01 July 2019
From
GNP+
PrEP policies and guidelines
Nine HIV diagnoses in men on PrEP waiting list, Manchester

Nine gay men are known to have seroconverted since being put on a waiting list for pre-exposure prophylaxis (PrEP) at a single Manchester clinic, Dr Sally Jewsbury

Published
01 July 2019
By
Roger Pebody
Pharmaceutical industry
What Are Gilead Sciences’ Key Growth Drivers in Fiscal 2019?

TAF (Tenofovir alafenamide)-based HIV therapy Biktarvy and cell therapy Yescarta emerged as the key growth drivers for Gilead Sciences (GILD) in the first quarter. Besides these drugs, the company also expects HIV PrEP (pre-exposure prophylaxis therapies) Truvada and Descovy to be its key growth drivers in the future.

Published
26 June 2019
From
Market Realist
Global health initiatives
Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction

A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, is justified today – when bigger global health threats now loom. Noncommunicable diseases now represent the lion’s share of the disease burden even in developing countries, critics say, but the current global health architecture allocates few resources towards those yawning needs.

Published
26 June 2019
From
Health Policy Watch
Side-effects
Cases of hair loss among African-American women reported after switch to new tenofovir formula

Hair loss (alopecia) occurred in six African-American women living with HIV after switching to the new formula of tenofovir, clinicians report in Open Forum Infectious Diseases. The

Published
26 June 2019
By
Michael Carter
← Prev1...34567...740Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.